Skip to content

GILD

Gilead Sciences, Inc.

Income statement

Income statement
Line, in USDLast 12 months2025202420232022202120202019201820172016201520142013201220112010200920082007
Revenue31.0B29.4B28.8B27.1B27.3B27.3B24.7B22.4B22.1B26.1B30.4B32.6B24.9B11.2B9.7B8.4B7.9B7.0B5.3B4.2B
Cost of revenue
6.22B6.23B6.25B6.50B5.66B6.60B4.57B4.68B4.85B4.37B4.26B4.01B3.79B2.86B2.47B2.12B1.87B1.60B1.13B0.77B
Gross profit24.8B23.2B22.5B20.6B21.6B20.7B20.1B17.8B17.3B21.7B26.1B28.6B21.1B8.3B7.2B6.3B6.1B5.4B4.2B3.5B
6.33B5.80B5.91B5.72B4.98B4.60B4.93B9.11B5.02B3.73B5.10B3.01B2.85B2.12B1.76B1.23B1.07B0.94B0.72B0.59B
6.81B5.77B6.09B6.09B5.67B5.25B5.15B4.38B4.06B3.88B3.40B3.43B2.98B1.70B1.46B1.24B1.04B0.95B0.80B0.71B
Other operating expenses
14.0B1.6B8.8B1.2B3.6B939M6.0B———————————11M—
Operating income−2.4B10.0B1.7B7.6B7.3B9.9B4.1B4.3B8.2B14.1B17.6B22.2B15.3B4.5B4.0B3.8B4.0B3.5B2.7B2.2B
Non-operating income
−0.17B−0.23B−0.97B−0.75B−1.52B−1.64B−2.40B0.87B−0.40B−0.60B−0.54B−0.53B−0.41B−0.32B−0.40B−0.14B−49M−27M−5.8M47M
Pretax income−2.5B9.8B690M6.9B5.8B8.3B1.7B5.2B7.8B13.5B17.1B21.7B14.9B4.2B3.6B3.7B3.9B3.5B2.7B2.2B
Taxes
1.33B1.29B0.21B1.19B1.22B2.05B1.55B−0.23B2.34B8.90B3.60B3.55B2.76B1.13B1.02B0.85B1.01B0.87B0.69B0.63B
Net income−3.9B8.5B480M5.7B4.6B6.2B123M5.4B5.5B4.6B13.5B18.1B12.1B3.1B2.6B2.8B2.9B2.6B2.0B1.6B
Diluted EPS−3.166.780.384.503.644.930.104.224.173.519.9411.917.351.811.641.771.661.411.030.82
Diluted shares—1.26B1.26B1.26B1.26B1.26B1.26B1.28B1.31B1.32B1.36B1.52B1.65B1.70B1.58B1.58B1.75B1.87B1.92B1.93B
Revenue growth—+2.4%+6.0%−0.6%−0.1%+10.6%+10.0%+1.5%−15.2%−14.1%−6.9%+31.1%+122.2%+15.5%+15.7%+5.5%+13.4%+31.4%+26.1%—
Gross margin79.9%78.8%78.3%76.0%79.3%75.8%81.5%79.2%78.1%83.3%86.0%87.7%84.8%74.5%74.5%74.7%76.5%77.2%78.9%81.8%
Operating margin−7.6%34.0%5.8%28.0%26.9%36.3%16.5%19.1%37.1%54.1%58.0%68.0%61.3%40.4%41.3%45.2%49.8%50.3%50.2%51.2%
Net margin−12.5%28.9%1.7%20.9%16.8%22.8%0.5%24.0%24.7%17.7%44.4%55.5%48.6%27.5%26.7%33.4%36.5%37.6%37.1%37.5%